Tatva Chintan Sets Record Date for AGM and Dividend on Sept 11, 2026
Tatva Chintan Pharma Chem Limited has set Friday, September 11, 2026, as the record date for its final dividend for FY2025-26. The 30th AGM is scheduled for September 25, 2026, with dividend payment on or after October 1, 2026. September 18, 2026, is the e-voting cut-off date.
This is a procedural announcement related to corporate events (AGM and dividend) and does not directly impact the company's financial performance or operational strategy.
The announcement is a routine intimation regarding the record date for the AGM and dividend payment, with no new financial information or significant business updates provided.
Tatva Chintan Pharma Chem Limited has announced the Record Date as Friday, September 11, 2026, for determining eligible equity shareholders for the final dividend for the Financial Year 2025-26. The Register of Members and Share Transfer Books will be closed from Saturday, September 12, 2026, to Friday, September 25, 2026, inclusive.
The 30th Annual General Meeting (AGM) is scheduled for Friday, September 25, 2026, at 04:00 p.m. IST, to be conducted through Video Conference/Other Audio Visual Means. The dividend, if approved at the AGM, will be paid on or after Thursday, October 01, 2026, within the statutory period of 30 days from the AGM date.
Furthermore, Friday, September 18, 2026, has been fixed as the cut-off date for shareholders to exercise their voting rights electronically or attend and vote during the AGM. This intimation is made pursuant to Regulation 42 and 44 of the SEBI Listing Regulations. The information will also be available on the company's website, www.tatvachintan.com.
What to do with a filing like this
Tatva Chintan Pharma Chem Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tatva Chintan Pharma Chem Limited. Read the original for the full detail.